Radioembolization versus chemoembolization for unresectable hepatocellular carcinoma: a meta-analysis of randomized trials

by Gardini, Andrea Casadei, Tamburini, Emiliano, Iñarrairaegui, Mercedes, Frassineti, Giovanni Luca, Sangro, Bruno
Published in Onco Targets Ther (2018)

Radiofrequency ablation of hepatocellular carcinoma: a meta-analysis of overall survival and recurrence-free survival

by Gardini, Andrea Casadei, Marisi, Giorgia, Canale, Matteo, Foschi, Francesco Giuseppe, Donati, Gabriele, Ercolani, Giorgio, Valgiusti, Martina, Passardi, Alessandro, Frassineti, Giovanni Luca, Scarpi, Emanuela
Published in Onco Targets Ther (2018)

IL-8 and thrombospondin-1 as prognostic markers in patients with metastatic colorectal cancer receiving bevacizumab

by Marisi, Giorgia, Scarpi, Emanuela, Passardi, Alessandro, Nanni, Oriana, Pagan, Flavia, Valgiusti, Martina, Gardini, Andrea Casadei, Neri, Luca Maria, Frassineti, Giovanni Luca, Amadori, Dino, Ulivi, Paola
Published in Cancer Manag Res (2018)

Prognostic role of serum concentrations of high-sensitivity C-reactive protein in patients with metastatic colorectal cancer: results from the ITACa trial

by Gardini, Andrea Casadei, Carloni, Silvia, Scarpi, Emanuela, Maltoni, Paolo, Dorizzi, Romolo M., Passardi, Alessandro, Frassineti, Giovanni Luca, Cortesi, Pietro, Giannini, Maria Benedetta, Marisi, Giorgia, Amadori, Dino, Lucchesi, Alessandro
Published in Oncotarget (2016)

Immunotherapeutic approaches for hepatocellular carcinoma

by Longo, Vito, Gnoni, Antonio, Gardini, Andrea Casadei, Pisconti, Salvatore, Licchetta, Antonella, Scartozzi, Mario, Memeo, Riccardo, Palmieri, Vincenzo Ostilio, Aprile, Giuseppe, Santini, Daniele, Nardulli, Patrizia, Silvestris, Nicola, Brunetti, Oronzo
Published in Oncotarget (2017)

Promoter methylation of tumor suppressor genes in pre-neoplastic lesions; potential marker of disease recurrence

by Rengucci, Claudia, De Maio, Giulia, Gardini, Andrea Casadei, Zucca, Mattia, Scarpi, Emanuela, Zingaretti, Chiara, Foschi, Giovanni, Tumedei, Maria Maddalena, Molinari, Chiara, Saragoni, Luca, Puccetti, Maurizio, Amadori, Dino, Zoli, Wainer, Calistri, Daniele
Published in J Exp Clin Cancer Res (2014)

Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib

by Gardini, Andrea Casadei, Scarpi, Emanuela, Faloppi, Luca, Scartozzi, Mario, Silvestris, Nicola, Santini, Daniele, de Stefano, Giorgio, Marisi, Giorgia, Negri, Francesca V., Foschi, Francesco Giuseppe, Valgiusti, Martina, Ercolani, Giorgio, Frassineti, Giovanni Luca
Published in Oncotarget (2016)

The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy

by Faloppi, Luca, Del Prete, Michela, Gardini, Andrea Casadei, Santini, Daniele, Silvestris, Nicola, Bianconi, Maristella, Giampieri, Riccardo, Valgiusti, Martina, Brunetti, Oronzo, Bittoni, Alessandro, Andrikou, Kalliopi, Lai, Eleonora, Dessì, Alessandra, Cascinu, Stefano, Scartozzi, Mario
Published in Sci Rep (2016)

Multicentric survey on dose reduction/interruption of cancer drug therapy in 12.472 patients: indicators of suspected adverse reactions

by Gardini, Andrea Casadei, Tenti, Elena, Masini, Carla, Nanni, Oriana, Scarpi, Emanuela, Valgiusti, Martina, Restuccia, Silvia, Gallani, Maria Laura, Palazzini, Simonetta, Bianchini, Erica, Menozzi, Silvia, Maugeri, Antonio, Amadori, Dino, Minguzzi, Martina, Frassineti, Giovanni Luca
Published in Oncotarget (2016)

Antiangiogenic agents after first line and sorafenib plus chemoembolization: a systematic review

by Gardini, Andrea Casadei, Santini, Daniele, Aprile, Giuseppe, Silvestris, Nicola, Felli, Emanuele, Foschi, Francesco Giuseppe, Ercolani, Giorgio, Marisi, Giorgia, Valgiusti, Martina, Passardi, Alessandro, Puzzoni, Marco, Silletta, Marianna, Brunetti, Oronzo, Cardellino, Giovanni Gerardo, Frassineti, Giovanni Luca, Scartozzi, Mario
Published in Oncotarget (2017)

Early onset of hypertension and serum electrolyte changes as potential predictive factors of activity in advanced HCC patients treated with sorafenib: results from a retrospective...

by Gardini, Andrea Casadei, Scarpi, Emanuela, Marisi, Giorgia, Foschi, Francesco Giuseppe, Donati, Gabriele, Giampalma, Emanuela, Faloppi, Luca, Scartozzi, Mario, Silvestris, Nicola, Bisulli, Marcello, Corbelli, Jody, Gardini, Andrea, Barba, Giuliano La, Veneroni, Luigi, Tamberi, Stefano, Cascinu, Stefano, Frassineti, Giovanni Luca
Published in Oncotarget (2016)

Prevalence of and risk factors for fatty liver in the general population of Northern Italy: the Bagnacavallo Study

by Foschi, Francesco Giuseppe, Bedogni, Giorgio, Domenicali, Marco, Giacomoni, Pierluigi, Dall’Aglio, Anna Chiara, Dazzani, Francesca, Lanzi, Arianna, Conti, Fabio, Savini, Sara, Saini, Gaia, Bernardi, Mauro, Andreone, Pietro, Gastaldelli, Amalia, Gardini, Andrea Casadei, Tiribelli, Claudio, Bellentani, Stefano, Stefanini, Giuseppe Francesco
Published in BMC Gastroenterol (2018)

eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: final results of the ePHAS study

by Gardini, Andrea Casadei, Marisi, Giorgia, Faloppi, Luca, Scarpi, Emanuela, Foschi, Francesco Giuseppe, Iavarone, Massimo, Lauletta, Gianfranco, Corbelli, Jody, Valgiusti, Martina, Facchetti, Floriana, Corte, Cristina della, Neri, Luca Maria, Tamberi, Stefano, Cascinu, Stefano, Scartozzi, Mario, Amadori, Dino, Nanni, Oriana, Tenti, Elena, Ulivi, Paola, Frassineti, Giovanni Luca
Published in Oncotarget (2016)